• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

CorMatrix Cardiovascular Inc.

CorMatrix launches FDA IDE Cor Tricuspid ECM cardiac valve trial

February 21, 2019 By Fink Densford

CorMatrix Cardiovascular said today that it launched a trial of its Cor Tricuspid ECM cardiac valve intended for treating adults with endocarditis and pediatric patients with congenital heart valve disease, adding that the first patient in the trial has already been treated. The first procedure in the trial took place at the Francicscan Health Heart Center […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Replacement Heart Valves Tagged With: CorMatrix Cardiovascular Inc.

CorMatrix wins FDA IDE approval for Cor Tricuspid ECM cardiac valve trial

January 24, 2019 By Fink Densford

CorMatrix Cardiovascular said today that it won FDA investigational device exemption approval to launch an early feasibility study of its Cor Tricuspid ECM cardiac valve intended for treating adults with endocarditis and pediatric patients with congenital heart valve disease. The Atlanta-based company touts its Cor Tricuspid valve as the first cardiac valve of its kind […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Replacement Heart Valves Tagged With: CorMatrix Cardiovascular Inc.

CorMatrix lands CE Mark for CanGaroo surgical envelope

June 28, 2016 By Brad Perriello

CorMatrix Cardiovascular said today that it won CE Mark approval in the European Union for its CanGaroo ECM surgical envelope for implanted cardiac devices. Roswell, Ga.-based CorMatrix won 510(k) clearance from the FDA in August 2014 for the CanGaroo device, which is designed to act as a scaffold to stimulate natural wound healing using CorMatrix’s extra-cellular matrix. […]

Filed Under: Cardiovascular, Regulatory/Compliance Tagged With: Cardiac Rhythm Management, CorMatrix Cardiovascular Inc.

CorMatrix launches Tyke cardiac tissue repair device for neonates

June 21, 2016 By Fink Densford

CorMatrix Cardiovascular said today it launched its CorMatrix Tyke cardiac tissue repair patch designed for correcting congenital heart defects in neonates and infants, touting the 1st successful procedures utilizing the patch. The CorMatrix Tyke is a patch designed to repair pericardial structures and as an epicardial covering or for intracardiac defects, septal defects, annulus repair, suture-line […]

Filed Under: Cardiac Implants, Cardiovascular, Regenerative Medicine Tagged With: CorMatrix Cardiovascular Inc.

Ligand Pharmaceuticals pays $18m for CorMatrix assets

May 6, 2016 By Brad Perriello

Ligand Pharmaceuticals (NSDQ:LGND) said this week that it’s getting into the medical device arena with the nearly $18 million acquisition of multiple tissue repair assets from CorMatrix. San Diego-based Ligand said it paid $17.5 million for synthetic royalties on existing extracellular matrix products, including the CanGaroo ECM envelope for implantable electronic devices, and the right […]

Filed Under: Cardiovascular, Mergers & Acquisitions, Pharmaceutical, Regenerative Medicine, Wall Street Beat Tagged With: CorMatrix Cardiovascular Inc., Ligand Pharmaceuticals

CorMatrix launches U.S. tricuspid valve device trial

March 17, 2016 By Fink Densford

CorMatrix Cardiovascular said today it enrolled the 1st patient in a trial of its CorMatrix ECM tricuspid valve designed from regenerative tissue. The early feasibility trial aims to demonstrate proof of principle and initial clinical safety at 8 U.S. centers, the Roswell, Ga.-based company said. CorMatrix is performing the trial under an investigative device exemption […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Regenerative Medicine Tagged With: CorMatrix Cardiovascular Inc.

Asahi Kasei shuffles the deck at Zoll Medical | Personnel Moves

March 10, 2016 By Brad Perriello

Japan’s Asahi Kasei Corp. (TYO:3407), which in 2012 paid $2.3 billion to acquire Zoll Medical, is shuffling the deck at the resuscitation device maker. Former CEO Rick Packer, who led Zoll for 13 years before overseeing the merger with Asahi Kasei, was promoted to primary executive officer and charged with building the healthcare business into “a 3rd […]

Filed Under: Business/Financial News Tagged With: Asahi Kasei Corp., CorMatrix Cardiovascular Inc., Dynatronics Corp, integer, LifeImage, Personnel Moves, Zoll Medical

CorMatrix wins FDA nod for Tyke neonate cardiac tissue

February 9, 2016 By Fink Densford

CorMatrix Cardiovascular said today it won FDA 510(k) clearance for its Tyke biomaterial for use in neonates and infants. The patch is designed to repair pericardial structures and as an epicardial covering or for intracardiac defects, septal defects, annulus repair, suture-line buttressing. The Tyke is derived from the company’s ECM technology platform and is composed […]

Filed Under: 510(k), Cardiovascular, Food & Drug Administration (FDA), Regenerative Medicine, Regulatory/Compliance Tagged With: CorMatrix Cardiovascular Inc.

CorMatrix lands FDA win, touts 1st human implant of CanGaroo surgical pouch

August 28, 2014 By Arezu Sarvestani Leave a Comment

CorMatrix lands FDA win, touts 1st human implant of CanGaroo surgical evelope

Georgia medical device maker CorMatrix touted an FDA win this month, landing regulatory clearance for its CanGaroo surgical envelope for securing implantable cardiac devices.

Filed Under: News Well, Regulatory/Compliance, Surgical Tagged With: Cardiac Rhythm Management, CorMatrix Cardiovascular Inc.

Press Release: CorMatrix reports FDA clearance of CorMatrix CanGaroo ECM Envelope

August 28, 2014 By MassDevice Contributors Network Leave a Comment

Press Release: CorMatrix reports FDA clearance of CorMatrix CanGaroo ECM Envelope

Roswell, Georgia – CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix CanGaroo ECM Envelope for use with cardiac implantable electronic devices (CIED’s) including pacemakers and implantable cardioverter defibrillators (ICD’s).

Filed Under: News Well, Regulatory/Compliance, Surgical Tagged With: Cardiac Rhythm Management, CorMatrix Cardiovascular Inc., Press Release

CorMatrix seeks $25M in equity round

January 21, 2014 By Chris Walker Leave a Comment

CorMatrix seeking $25M in equity funding round

CorMatrix Cardiovascular is seeking $25 million in an equity offering.

The Roswell, Ga.-based medical device company makes cardiovascular devices designed to treat damaged heart tissue. The CorMatrix flagship product is a biomaterial implant designed to help the heart heal itself.

Filed Under: Cardiovascular, Funding Roundup, News Well Tagged With: CorMatrix Cardiovascular Inc.

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy